The intima: soil for atherosclerosis and restenosis SM Schwartz, D deBlois, ERM O’Brien Circulation research 77 (3), 445-465, 1995 | 1277 | 1995 |
Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats D deBlois, BS Tea, TV Dam, J Tremblay, P Hamet Hypertension 29 (1), 340-344, 1997 | 225 | 1997 |
Chondroitin Sulfate Inhibits the Nuclear Translocation of Nuclear Factor‐κB in Interleukin‐1β‐Stimulated Chondrocytes C Jomphe, M Gabriac, TM Hale, L Héroux, LÉ Trudeau, D Deblois, ... Basic & clinical pharmacology & toxicology 102 (1), 59-65, 2008 | 184 | 2008 |
Studies on the induction of pharmacological responses to des‐Arg9‐bradykinin in vitro and in vivo J Bouthillier, D Deblois, F Marceau British journal of pharmacology 92 (2), 257-264, 1987 | 179 | 1987 |
Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development M Benderdour, G Charron, D DeBlois, B Comte, C Des Rosiers Journal of Biological Chemistry 278 (46), 45154-45159, 2003 | 148 | 2003 |
Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-bradykinin. D Deblois, J Bouthillier, F Marceau British journal of pharmacology 93 (4), 969, 1988 | 135 | 1988 |
Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo BS Tea, S Der Sarkissian, RM Touyz, P Hamet, D deBlois Hypertension 35 (5), 1069-1073, 2000 | 134 | 2000 |
Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation L Liaw, DM Lombardi, MM Almeida, SM Schwartz, D deBlois, ... Arteriosclerosis, thrombosis, and vascular biology 17 (1), 188-193, 1997 | 134 | 1997 |
Sequential activation of matrix metalloproteinase 9 and transforming growth factor β in arterial elastocalcinosis C Bouvet, S Moreau, J Blanchette, D de Blois, P Moreau Arteriosclerosis, thrombosis, and vascular biology 28 (5), 856-862, 2008 | 123 | 2008 |
The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. P Hamet, P Moreau, TV Dam, SN Orlov, BS Tea, D De Blois, J Tremblay Journal of hypertension. Supplement: Official Journal of the International …, 1996 | 110 | 1996 |
Pulse exposure to protein synthesis inhibitors enhances vascular responses to des‐Arg9‐bradykinin: possible role of interleukin‐1 D deBlois, J Bouthillier, F Marceau British journal of pharmacology 103 (1), 1057-1066, 1991 | 110 | 1991 |
Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes MR Brodeur, C Bouvet, S Bouchard, S Moreau, J Leblond, D Deblois, ... PloS one 9 (1), e85922, 2014 | 97 | 2014 |
Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition C Bouvet, LA Gilbert, D Girardot, D deblois, P Moreau Hypertension 45 (3), 432-437, 2005 | 96 | 2005 |
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats: temporal regulation and spatial heterogeneity BS Tea, TV Dam, P Moreau, P Hamet, D deBlois Hypertension 34 (2), 229-235, 1999 | 96 | 1999 |
Inhibition of Vascular Smooth Muscle Cell Proliferation and Neointimal Formation in Injured Arteries by a Novel, Oral Mitogen-Activated Protein Kinase/Extracellular Signal … G Gennaro, C Ménard, SÉ Michaud, D Deblois, A Rivard Circulation 110 (21), 3367-3371, 2004 | 95 | 2004 |
Apoptosis and vascular wall remodeling in hypertension P Hamet, D deBlois, TV Dam, L Richard, E Teiger, BS Tea, SN Orlov, ... Canadian journal of physiology and pharmacology 74 (7), 850-861, 1996 | 82 | 1996 |
Inhibition of Na+, K+-ATPase by ouabain triggers epithelial cell death independently of inversion of the [Na+] i/[K+] i ratio D Pchejetski, S Taurin, S Der Sarkissian, OD Lopina, AV Pshezhetsky, ... Biochemical and biophysical research communications 301 (3), 735-744, 2003 | 78 | 2003 |
Angiotensin II induction of osteopontin expression and DNA replication in rat arteries D deBlois, DM Lombardi, EJ Su, AW Clowes, SM Schwartz, CM Giachelli Hypertension 28 (6), 1055-1063, 1996 | 78 | 1996 |
Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development M Benderdour, G Charron, B Comte, R Ayoub, D Beaudry, S Foisy, ... American Journal of Physiology-Heart and Circulatory Physiology 287 (5 …, 2004 | 76 | 2004 |
Pharmacological modulation of the up-regulated responses to des-Arg9-bradykinin in vivo and in vitro D deBlois, J Bouthillier, F Marceau Immunopharmacology 17 (3), 187-198, 1989 | 74 | 1989 |